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Prolonged tissue ischemia leads to changes in microcirculation and production of oxygen free radicals. The event eventually
responsible for tissue death is the no-reflow phenomenon and its management is a challenge for the surgeon dealing with
replantation or transplantation. We introduce a model of warm ischemia and reperfusion of the lower limb of rats with which
we studied the effect of allopurinol and streptokinase.
METHOD: Section of the lower limb with preservation of vessels and nerves was performed in 110 rats. Femoral vessels
clamped for periods of 0, 2, 4, 6, and 8 hours of ischemia were allowed to reperfuse (groups M0, M2, M4, M6, and M8
respectively). Other groups, E1, E2, and E3, received streptokinase, allopurinol, or a combination of the two drugs after 6
hours of ischemia.
RESULTS: Viability rates of the ischemic limbs after 7 days were 100% (M0), 80% (M2), 63.6% (M4), 50% (M6), and 20%
(M8). In the experimental groups, E1, E2, and E3, viability rates were 67% (E1), 70% (E2), and 70% (E3). Groups M0, M2,
M4, M6, and M8 differed among themselves except for groups M4 and M6. Group E1 had a higher rate of limb viability than
M6 (control group) but not than M4. Groups E1, E2 and E3 had higher rates of limb viability than M6 but not than M2 or
M4.
DISCUSSION: The results suggest that increased viability of limbs after 6 hours of ischemia occurs when allopurinol or
streptokinase is used. The combination of the two drugs does not appear to produce any additional effect.
KEYWORDS: Warm ischemia. No-reflow phenomenon. Free radicals. Rat limb.
Replantation of extremities after amputation or major
trauma is not always successful, and the most important fac-
tor is the time elapsed from the beginning of ischemia. Vi-
ability and final functional result depend on the preven-
tion of damaging effects of anoxia. The involved tissues
have different resistances to anoxia. Skeletal muscle is the
least tolerant to ischemia and the anatomical, metabolic,
and pathophysiological effects having been thoroughly
studied.1-3 Maintenance of muscle viability is critical for
the success of replantation.
The effort to improve limb viability has led authors to
introduce different models to study ischemic limb perfusion
and the effect of different drugs on survival rates.4 No con-
sensus exists regarding the best model for studying
ischemia, and limb survival rates differ from model to
model. Successful replantations with longer periods of
ischemia have been reported.1
Although microsurgical anastomosis is critical, the distal
capillary circulation is equally important in terms of the
viability of microsurgical flaps and replanted limbs. Pro-
longed ischemia followed by reperfusion produces irrevers-
ible damage to microcirculation, leading to obstruction of
blood flow to peripheral tissues. These alterations to mi-
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crocirculation constitute the no-reflow phenomenon.3,5-9
Obstruction is progressive, with thrombus formation in the
microcirculation, platelet aggregation, and tissue edema. Ir-
reversible damage and loss of limb or of microsurgical flap
can result.2,8,10,11
The possible role of oxygen free radicals in the
pathogenesis of tissue lesions after reperfusion has been stud-
ied, as has the use of pharmacological agents to prevent this
phenomenon.12,13 Encouraging results have been obtained
using antioxidants , as well as a number of other drugs and
agents in different tissues.5,14,15 The superoxide radical is cre-
ated in all aerobic organisms under various conditions and
causes peroxidation of membranes and proteins resulting in
tissue destruction and irreversible cell injury. 2,7,16,17
Vascular thrombosis is a significant complication in
microsurgery. There are several causes for thrombosis, all
of which may lead to failure of a microvascular anastomo-
sis.18,19 Some factors are inherent to replanted tissues, while
others depend on surgical technique. Tissue trauma has
been recognized as the main cause of limb loss.20 Various
anti-thrombotic and anti-inflammatory drugs have been
studied in experimental flaps in trying to prevent vascular
thrombosis.19,21
An animal model using rats was developed in the Labo-
ratory for Experimental Microsurgery at the Fac. Med. Univ.
São Paulo to determine the maximum ischemic period tis-
sues can sustain and the influence of different drugs on the
prevention of deleterious effects of warm ischemia and
reperfusion. This paper presents this experimental model of
warm ischemia and reperfusion and its use in assessing the
effect of allopurinol and streptokinase on the survival of
the extremities.
METHOD
This project was approved by the Institutional Ethics
Committee, and follows the NIH guidelines for animal ex-
periments.
One hundred and ten male Wistar rats ranging in age
from 16 to 20 weeks and weighing between 290 and 400 g
were used. The animals were maintained in individual cages
with food and water ad libitum, a light/dark period of 12/
12 hours, and a room temperature of 23oC. The same sur-
geon performed all surgical procedures.
Surgical procedure
The animals were anesthetized using intraperitoneal so-
dium pentobarbital (50 mg/kg) injection. A subtotal ampu-
tation of the right posterior limb was accomplished, pre-
serving the femoral vessels and the sciatic nerve.
A circular incision in the mid-portion of the thigh was
performed around the entire circumference including skin
and subcutaneous tissue. Femoral vessels and nerve were
dissected using a surgical microscope (Karl Kaps model D-
35614 ASSLAR - 16X magnification), and muscles of the
mid-third thigh were severed, but the sciatic nerve was iden-
tified and kept intact. Osteotomy of the mid-third of the
femur was performed with a manual saw (Fig. 1). Those tis-
sues were immediately reconstructed, starting with the bone,
by intramedullary fixation of the femur with a 2 cm needle
segment and instant cyanoacrylate ester glue. Horizontal
U stitches of 5-0 nylon were used for the muscle synthesis.
An atraumatic microvascular clamp was applied to right
femoral vessels before the emergence of the superficial cau-
dal epigastric vessels, avoiding the inclusion of the femo-
ral nerve (Fig. 2). A negative milking test certified inter-
ruption of arterial and venous flow, and ischemia was con-
sidered to be complete.
Figure 1 - Amputated limb with preservation of vessels and nerves.
Figure 2 - Limb undergoing replantation and positioning of the
microvascular clamp
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Fluid volume was replaced postoperatively by a subcu-
taneous injection of 50 mL/kg of saline. The mean time for
subtotal amputation and replantation was 33 minutes (range,
15-45 minutes). Twenty-one animals died during surgery or
within 7 postoperative days, a perioperative mortality rate
of 19%. This mortality rate was similar to that experienced
by Ferreira et al.1 (25.5%) and Shapiro22 et al. (15.4%).
Period of warm ischemia
The animals were submitted to different times of warm
ischemia after the vessels were clamped. During this period
they were allowed to recover in individual cages at a room
temperature of 25oC, achieved using a 45 W and 127 V halo-
gen lamp that was maintained 30 cm from the cage.
Reperfusion
At the end of the ischemic period, rats were
reanesthetized. Dissection of the left femoral vessels and
their branches was performed, a needle (29G) was inserted
in the superficial caudal epigastric vein, 1 mL of saline,
streptokinase, allopurinol, or streptokinase/alopurinol was
injected, and the vascular clamp was removed.
Patency of the femoral vessels was confirmed by a posi-
tive milking test and absence of thrombi. The presence of
thrombi and absence of flow in femoral vessels excluded
the animal from the experiment.
Groups
The animals were divided into 5 model groups with 10
to 12 rats each that were submitted to ischemic periods of
0, 2, 4, 6, and 8 hours (M0, M2, M4, M6, and M8, respec-
tively). It was determined that 6 hours of warm ischemia
(M6) would be used as the control for the experimental
groups. Three experimental groups with 10 or 12 animals
per group were submitted to 6 hours of ischemia and re-
ceived intravenous solutions of streptokinase, allopurinol
or streptokinase/allopurinol (E1, E2, and E3, respectively)
after 6 hours and immediately before the vascular clamp
was removed (Table 1).
Allopurinol was diluted in 1N sodium hydroxide until
it fully dissolved. Hydrochloric acid (1N) was added to this
alkaline solution until the start of allopurinol precipitation
, indicating the minimum pH for solubility. A final drop of
1N sodium hydroxide was used to redissolve the precipi-
tate, and water was added to obtain the necessary final vol-
ume. One mL of the resulting solution contained 45 mg/kg
of allopurinol (Allopurinolâ—Sigma Aldrich).
The streptokinase solution used contained 20000 IU/
kg of streptokinase (Streptaseâ 1500000 IU—Hoeschst
Marion Roussel) diluted in 1 ml of 0.9% saline.
Analysis of limb viability
The animals were observed daily over a 7-day period.
Limb viability was determined by clinical examination as
an all-or-nothing response. A nonviable limb was defined
by total limb necrosis. A viable limb was defined by total
limb survival or total survival with partial necrosis of the
skin near the suture with viable underlying muscle and nor-
mal hair growth.
Results were converted into percentage of limb viabil-
ity per group. The groups were compared among themselves
and analyzed using the chi-square test. The level of sig-
nificance was set at 5% (P < .05).
RESULTS
Groups
Group M0 was submitted to 0 hours of ischemia and
displayed a 100% limb viability rate (LVR). The LVR of
the groups progressed as follows: M2, 80%; M4, 64%; M6,
50%; and M8, 20%. Differences between groups M0 vs. M2,
M2 vs. M4, and M6 vs. M8 were statistically significant.
The difference between groups M4 vs. M6 was not statisti-
cally significant.
After 6 hours of ischemia, group E1 (streptokinase) dis-
played an LVR of 67%, which was statistically different
from that of group M6 (6 hours and no drug) (P < .05). No
statistical difference was observed in the VLR rate between
groups E1 and M4 (4 hours and no drug).
Group E2 (allopurinol) progressed with an LVR of 70%
that was statistically different from that of group M6 (P <
.05), but not from M2 or M4.
The association of allopurinol and streptokinase (E3)
Table 1 - Groups, number of animals, ischemic period, and
solutions.
Groups N Ischemic period Solutions
M0 10 0 h Saline
M2 10 2 h Saline
M4 11 4 h Saline
M6 10 6 h Saline
M8 10 8 h Saline
E1 12 6 h Streptokinase*
E2 10 6 h Allopurinol**
E3 10 6 h Streptokinase/Allopurinol
*solution containing 20000 IU/kg of streptokinase diluted in 9% saline.
(Streptase® 1500000 IU—Hoeschst Marion Roussel)
**solution containing 45 mg/kg of allopurinol. (Allopurinol®—Sigma
Aldrich)
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had an LVR of 70% and was statistically different from that
of M6 (P < .05). No statistical difference was observed be-
tween E3 and M2 or M4.
Differences among groups E1, E2, and E3 were not sta-
tistically significant.
Fig. 3 and 4 (graphs)
DISCUSSION
A variety of causes have been proposed for the no-
reflow phenomenon. Ames et al.,7 in 1968, first described a
no-reflow phenomenon in areas of ischemic brain. Miller
et al.23 observed that arteriovenous shuntings occurred in
replanted limbs, and this could also reduce blood flow.
May et al.6 mentioned that stasis and loss of intravascular
fluid with consequent exposure of subintimal collagen could
lead to thrombosis after replantation. Urbaniak et al.24 clas-
sified the multiple factors responsible for the no-reflow phe-
nomenon into 3 groups: ischemia, injury to the vascular
intima, and systemic and local responses. This triad leads
to histological and metabolic changes in the microcircula-
tion that include vasoconstriction of arterioles, endothelial
Figure 3 - Model groups. Statistically significant differences occurred between every consecutive pair, except M4 vs. M6.
Figure 4 - Experimental groups. Streptokinase and Allopurinol viability rates. The combination produced no further improvement.
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edema, regional blood stasis, adhesion and migration of
leukocytes, focal hemorrhage, platelet aggregation, produc-
tion of oxygen free radicals, and acidosis.
Several experimental models have been developed to
study this phenomenon. Stock et al.25 observed irreversible
metabolic changes after 4 hours of ischemia of rat hind
limbs. Swartz et al.26 reported 100% necrosis of rat hind
limbs submitted to 6 hours of ischemia.
Zdeblick et al.27 studied replanted posterior rat limbs af-
ter several hours of ischemia and observed that limb viabil-
ity exhibited an all-or-nothing response. After 2 or 3 hours
of ischemia, viability rates were 100%, after 4 hours the vi-
ability rate dropped to 50%, and after 6 hours, 20%.
Edwards et al.28 also observed an all-or-nothing response
in survival of rat hind limbs after replantation. The limbs
were submitted to warm ischemia for 5 hours and the re-
sulting LVR was 50%. Concannon et al.29 obtained an LVR
of 30% in posterior rat limbs submitted to 6 hours of warm
ischemia and also observed an all-or-nothing response.
Olivas et al.30 studied ischemia of the rat’s cremaster mus-
cle and observed that 7 or 8 hours of ischemia is the criti-
cal time for reversibility of reperfusion injuries in muscles.
The operative procedure in the present study consisted
of subtotal hind limb amputation, keeping intact the vascu-
lar pedicle and nerve, a model which is similar to that used
by Concannon et al.29 Keeping the vascular pedicle intact
avoided the need for microvascular anastomosis and a new
variable to be controled.22 The intact sciatic nerve prevented
loss of sensibility and limb autophagia. which was only ob-
served after the fourth postoperative day when there was
necrosis of the limb. Concannon et al.29 described autophagia
in viable and nonviable limbs with nerve injury.
Body fluid volume was replaced with 50 mL/kg of sa-
line. Blood loss via bone marrow in intramedullary fixa-
tion was reported as cause of death by Ferreira et al.1 In-
stant glue was used in this study for bone synthesis so as
to avoid blood loss through the bone marrow.
In order to determine the critical time of ischemia, 5
groups were compared, ranging from immediate reperfusion
to 8 hours, and in accordance with reported data, and an
all-or-nothing response was recorded. The results evidenced
a negative correlation between ischemic time and viabil-
ity, therefore conferring reliability to the ischemia model.
Effect of streptokinase
Microvascular thrombosis is an important component
of the no-reflow phenomenon. Blood stasis, endothelial
ischemic injury, and exposure of the subendothelium acti-
vate the coagulation cascade and lead to formation of fi-
brin and platelet aggregation. Fibrinolytic drugs have been
used in microsurgery as prophylaxis for preventing throm-
bosis of anastomosis. Urokinase, heparin, and prostaglan-
din E1 were part of the replantation protocol of Yamano31
and of Fukui & Tamai.32 Vertos & Tsavissis18 have used
streptokinase and low molecular weight dextran routinely
after replants. Fibrinolytic drugs can also be employed
therapeutically to reduce the effects of ischemia injury.
Their effectiveness has been shown in clinical treatment of
various thrombotic pathologies, such as acute coronary ar-
terial thrombosis, deep venous thrombosis, and pulmonary
thromboembolism.
The role of thrombolytic agents in preserving viability
in microsurgical flaps and replants is not fully established.
A number of drugs have been tested with controversial re-
sults. More recently, streptokinase and rt-PA have been suc-
cessfully used in replants and in experimental models of
thrombosis.19
In this study, group E1 received an intravenous dose of
20,000 IU/kg of streptokinase after 6 hours of warm
ischemia. This dose was based on those used clinically for
systemic fibrinolysis and was also used by Busnardo et al.19
to study thrombosis in microsurgical anastomosis.
The LVR after streptokinase (67 %) was better and sig-
nificantly different from the control group M6 (50%). This
result suggests that limbs submitted to 6 hours of ischemia
and treated with streptokinase were protected compared to
controls.
Effect of allopurinol
There are several references regarding the benefits of al-
lopurinol and other antioxidants in ischemic models in
fasciocutaneous flaps in rats and pigs.5,9,14,29
In this study, group E2 underwent limb ischemia for 6
hours and was treated with 45 mg/kg of intravenous allopu-
rinol. Concannon et al.29 also used this dose and adminis-
tration route.
The LVR of the allopurinol group (70%) was signifi-
cantly higher than that of group M6 (50%). This data sug-
gests that 6-hour ischemic limbs treated with allopurinol
were protected compared to controls.
No statistical difference was found between groups E2
(70%) and E3 (70%), implying that there was no additional
benefit from using a combined streptokinase-allopurinol
treatment.
These data are similar to results found by Concannon
et al.,29 in which a viability rate of 60% was observed in 6-
hour ischemic rat limbs after administration of allopurinol.
Ferrari et al.33 noticed a reduction in compartmental pres-
sure of amputated rat limbs with various ischemic times and
administration of allopurinol.
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In summary, the proposed rat hind limb experimental
model is simple, and it has a low rate of complications and
mortality. It is reliable and suitable for studying ischemia,
reperfusion, and the no-reflow phenomenon with an all-or-
nothing response.
This report demonstrated that viability rates of limbs af-
ter 6 hours of ischemia increased from 50% to 64% with
streptokinase administration and to 70% with allopurinol.
No additional effect was obtained with the combination of
these drugs.
In summary, the proposed rat hind limb experimental
model is simple, and it has a low rate of complications and
mortality. It is reliable and suitable for studying ischemia,
reperfusion, and the no-reflow phenomenon with an all-or-
nothing response.
This report demonstrated that viability rates of limbs af-
ter 6 hours of ischemia increased from 50% to 64% with
streptokinase administration and to 70% with allopurinol.
No additional effect was obtained with the combination of
these drugs.
RESUMO
Cunha MS, Silva JCF da, Nakamoto HA, Ferreira MC. Es-
tudo da isquemia quente e reperfusão em membro inferior
de ratos: efeito do allopurinol e estreptokinase. Clinics.
2005;60(3):213-20.
A isquemia prolongada dos tecidos leva a alterações na
microcirculação e liberação de radicais livres do oxigênio,
evento que pode resultar na morte do tecido, conhecido
como fenômeno de não reperfusão. Um modelo em ratos
de isquemia quente e reperfusão do membro posterior é pro-
posto, e os efeitos dos fármacos alopurinol e estreptoqui-
nase foram estudados.
MÉTODO: Secção do membro posterior com preservação
dos vasos e nervos foi realizada em 110 ratos. O pinçamento
vascular e posterior reperfusão após isquemia quente de 0,
2, 4, 6 e 8 horas formou os grupos M0, M2, M4, M6 e M8
respectivamente. Outros grupos E1, E2 e E3 receberam, res-
pectivamente, alopurinol, estreptoquinase e a combinação
de ambas as drogas, após seis horas de isquemia.
RESULTADOS: As taxas de viabilidade dos membros
isquêmicos, observadas após sete dias foram: M0 - 100%,
M2 - 80% ,M4 - 64%,M6 - 50% e M8 - 20%. As taxas de
viabilidade dos grupos experimentais foram 67%(E1),
70%(E2) e 70%(E3). Os grupos M0, M2, M4, M6 e M8 fo-
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